HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
-2.42%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.12B
AUM Growth
+$2.12B
(-2.8%)
Cap. Flow
+$4.3M
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
27.01%
Holding
230
New
15
Increased
79
Reduced
119
Closed
12
Top Buys
| 1 |
Agilent Technologies
A
|
$47.7M |
| 2 |
Costco
COST
|
$18.4M |
| 3 |
Applied Materials
AMAT
|
$18.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$8.06M |
| 5 |
Intuitive Surgical
ISRG
|
$5.72M |
Top Sells
| 1 |
Pfizer
PFE
|
$43M |
| 2 |
Qualcomm
QCOM
|
$16.7M |
| 3 |
Walt Disney
DIS
|
$15.7M |
| 4 |
Eli Lilly
LLY
|
$8.98M |
| 5 |
NVIDIA
NVDA
|
$5.78M |
Sector Composition
| 1 | Healthcare | 50.85% |
| 2 | Technology | 18.89% |
| 3 | Financials | 7.41% |
| 4 | Consumer Discretionary | 5.83% |
| 5 | Communication Services | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $71.9M | 3.39% | 142,587 -7,639 | -5% | -$3.85M |
|
2
Johnson & Johnson
JNJ
$427B
| $67.6M | 3.19% | 434,191 +3,822 | +0.9% | +$595K |
|
3
Amgen
AMGN
$155B
| $59M | 2.79% | 219,556 -5,980 | -3% | -$1.61M |
|
4
AbbVie
ABBV
$372B
| $54.6M | 2.58% | 366,248 +6,266 | +2% | +$934K |
|
5
AstraZeneca
AZN
$248B
| $53.8M | 2.54% | 794,033 +82,223 | +12% | +$5.57M |
|
6
Boston Scientific
BSX
$156B
| $53.6M | 2.53% | 1,014,749 +20,969 | +2% | +$1.11M |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $53.2M | 2.51% | 64,602 -4,659 | -7% | -$3.83M |
|
8
Merck
MRK
$210B
| $52.9M | 2.5% | 514,151 +52,886 | +11% | +$5.44M |
|
|
9
Bristol-Myers Squibb
BMY
$96B
| $52.8M | 2.49% | 909,437 +138,917 | +18% | +$8.06M |
|
10
Novartis
NVS
$245B
| $52.7M | 2.49% | 517,617 +28,079 | +6% | +$2.86M |
|
|
11
Eli Lilly
LLY
$657B
| $51.5M | 2.43% | 95,956 -16,719 | -15% | -$8.98M |
|
|
12
Intuitive Surgical
ISRG
$170B
| $51.2M | 2.42% | 175,264 +19,564 | +13% | +$5.72M |
|
13
Zoetis
ZTS
$69.3B
| $51.1M | 2.41% | 293,881 -9,322 | -3% | -$1.62M |
|
14
Stryker
SYK
$150B
| $51M | 2.41% | 186,786 +8,077 | +5% | +$2.21M |
|
15
Danaher
DHR
$147B
| $50.8M | 2.4% | 204,881 -12,072 | -6% | -$3M |
|
16
Elevance Health
ELV
$71.8B
| $50M | 2.36% | 114,717 -4,361 | -4% | -$1.9M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $49.5M | 2.33% | 97,699 +3,476 | +4% | +$1.76M |
|
18
Medtronic
MDT
$119B
| $49.3M | 2.33% | 628,656 +60,063 | +11% | +$4.71M |
|
19
Abbott
ABT
$231B
| $49M | 2.31% | 506,041 +34,041 | +7% | +$3.3M |
|
|
20
Agilent Technologies
A
$35.7B
| $47.7M | 2.25% | +426,938 | New | +$47.7M |
|
21
Accenture
ACN
$162B
| $37.6M | 1.78% | 122,591 -2,957 | -2% | -$908K |
|
22
Alphabet (Google) Class A
GOOGL
$2.57T
| $36.9M | 1.74% | 282,079 -30,553 | -10% | -$4M |
|
23
Microsoft
MSFT
$3.77T
| $36.7M | 1.73% | 116,359 +3,833 | +3% | +$1.21M |
|
24
Texas Instruments
TXN
$184B
| $34.3M | 1.62% | 215,889 +12,172 | +6% | +$1.94M |
|
25
Apple
AAPL
$3.45T
| $29.5M | 1.39% | 172,262 -29,733 | -15% | -$5.09M |
|